Science Explorer Interactive view Map
Company · Cambridge · United States

Sarepta Therapeutics (United States)

In research, Sarepta Therapeutics (United States) stands highest in Life Sciences (#8,203 of 14,347 worldwide) and Biochemistry, Genetics and Molecular Biology (#6,600 of 7,814 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology and Biochemistry, Genetics and Molecular Biology — Molecular Biology is 9.8× its share of world research.

World rank, 2022–2025
#22,425
of 28,054 · #18,070 all time
Rank in United States
#3,326
of 4,192
Research works
314
▲ 123% vs 2013–17
Citations
11k
33.6 per fractional work
Top-10% rate
11.0%
record average 16.5%
Open access
41%
world 28%

What is Sarepta Therapeutics (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #8,203 of 14,347 23.0%161
Biochemistry, Genetics and Molecular BiologyField #6,600 of 7,814 21.7%136

Each strip is that field’s whole ranked pool, with the notch where Sarepta Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Sarepta Therapeutics (United States) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 9.8× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 32.8 works9.8×
  2. Biochemistry, Genetics and Molecular BiologyField · 42.9 works7.3×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.28× its world share, 43 worksBiochemistry, Geneti…Immunology and Microbiology: 1.55× its world share, 2 worksImmunology and Micro…Neuroscience: 1.10× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.07× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.59× its world share, 4 worksChemistryComputer Science: 0.12× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.14× its world share, 0 worksEarth and Planetary …Engineering: 0.24× its world share, 4 worksEngineeringEnvironmental Science: 0.05× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.16× its world share, 1 worksMaterials ScienceMathematics: 0.76× its world share, 1 worksMathematicsHealth Professions: 0.30× its world share, 1 worksHealth ProfessionsMedicine: 1.83× its world share, 39 worksMedicineNursing: 0.38× its world share, 0 worksNursingVeterinary: 1.76× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.44× its world share, 2 worksBusiness, Management…Decision Sciences: 0.44× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.39× its world share, 6 worksEconomics, Econometr…Psychology: 0.24× its world share, 1 worksPsychologySocial Sciences: 0.17× its world share, 2 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.3×. Every wedge is a field page.

Who are the top researchers at Sarepta Therapeutics (United States)?

Ranked on the composite score, Patrick L. Iversen and Katherine Gooch lead among researchers whose main affiliation is Sarepta Therapeutics (United States).

  1. 1 Patrick L. Iversen United States · #296,662 worldwide 183 citations · 55 works
  2. 2 Katherine Gooch United States · #1,403,675 worldwide 20 citations · 27 works
All ranked researchers at Sarepta Therapeutics (United States)

Which keywords describe research at Sarepta Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Stem Cells, Muscle Regeneration, Skeletal Muscle Atrophy, Gene Therapy, Regenerative Medicine, Genomic Integration, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Stem Cells20▲ 70×2 topics
  2. Muscle Regeneration20▲ 666×1 topic
  3. Skeletal Muscle Atrophy20▲ 666×1 topic
  4. Epidemiology7▲ 1.51×24 topics
  5. Gene Therapy6▲ 29×3 topics
  6. Regenerative Medicine5▲ 18×3 topics
  7. Genomic Integration5▲ 74×2 topics
  8. Clinical Trials5▲ 6.2×6 topics
  9. Quality of Life5▲ 2.9×6 topics
  10. Treatment4▲ 3.3×12 topics
  11. Cost-effectiveness Analysis4▲ 45×1 topic
  12. Health Utility Measures4▲ 45×1 topic
  13. AAV4▲ 95×1 topic
  14. Viral Vectors4▲ 95×1 topic
  15. Patient Safety4▲ 25×3 topics
  16. Translational Research4▲ 104×2 topics
  17. Antisense Oligonucleotides4▲ 86×2 topics
  18. Regulatory Challenges4▲ 41×1 topic
  19. Stem Cell Regulation4▲ 160×1 topic
  20. Immunotherapy4▲ 5.0×6 topics
  21. Rehabilitation4▲ 8.7×3 topics
  22. Neuromuscular Junction4▲ 79×2 topics
  23. SMN14▲ 146×1 topic
  24. Spinal Muscular Atrophy4▲ 146×1 topic
  25. Cancer Immunotherapy3▲ 20×2 topics
  26. Genetic Mutations3▲ 7.1×7 topics
  27. CAR T Cells3▲ 39×1 topic
  28. Chimeric Antigen Receptor3▲ 39×1 topic
  29. Gene Expression3▲ 4.1×7 topics
  30. Transcriptional Regulation3▲ 15×3 topics
  31. Mitochondrial Dysfunction3▲ 8.2×6 topics
  32. Exoskeletons2▲ 72×1 topic
  33. Lower Limb2▲ 72×1 topic
  34. Epigenetic Regulation2▲ 9.8×2 topics
  35. Arginine Methylation2▲ 67×1 topic
  36. Protein Arginine Methyltransferases2▲ 67×1 topic
  37. Protein Aggregation2▲ 30×2 topics
  38. RNA Interference2▲ 18×1 topic
  39. Urolithiasis2▲ 64×1 topic
  40. siRNA Delivery2▲ 26×1 topic

Which research topics does Sarepta Therapeutics (United States) publish most on?

By volume in 2022–2025: Muscle Physiology and Disorders, Health Systems, Economic Evaluations, Quality of Life, Virus-based gene therapy research and Biomedical Ethics and Regulation.

  1. 1 Muscle Physiology and Disorders Molecular Biology 20 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  3. 3 Virus-based gene therapy research Genetics 4 works
  4. 4 Biomedical Ethics and Regulation Physiology 4 works
  5. 5 Neurogenetic and Muscular Disorders Research Genetics 4 works
  6. 6 CAR-T cell therapy research Oncology 3 works
  7. 7 Prosthetics and Rehabilitation Robotics Biomedical Engineering 2 works
  8. 8 Cancer-related gene regulation Molecular Biology 2 works
  9. 9 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 2 works
  10. 10 RNA Interference and Gene Delivery Molecular Biology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.1%not open58.9%

World: 28% of research is openly available.

with international co-authors26.2%domestic only73.8%

World: 19% is written across borders.

How has Sarepta Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 123% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.